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Background: Globally, an estimated 54 million people have angina, 16 million of whom are from the WHO
South-East Asia region. Despite the increasing burden of cardiovascular disease (CVD) in South Asia, there is no
evidence of an economic burden of angina on households in this region. We investigated the economic burden of
angina on households in South Asia.
Methods: We applied a novel propensity score matching approach to assess the economic burden of angina on
household out-of-pocket (OOP) health spending, borrowing or selling assets, non-medical consumption
expenditure, and employment status of angina-affected individual using nationally representative World Health
Survey data from Bangladesh, India, Nepal and Sri Lanka collected during 2002-2003. We used multiple matching
methods to match households where the respondent reported symptomatic or diagnosed angina with control
households with similar propensity scores.
Results: Angina-affected households had significantly higher OOP health spending per person in the four weeks
preceding the survey than matched controls, in Bangladesh (I$1.94, p = 0.04), in Nepal (I$4.68, p = 0.03) and in Sri
Lanka (I$1.99, p < 0.01). Nearly half of this difference was accounted for by drug expenditures. Catastrophic
spending, defined as the ratio of OOP health spending to total household expenditure in excess of 20%, was
significantly higher in angina-affected households relative to matched controls in India (9.60%, p < 0.01), Nepal
(4.90%, p = 0.02) and Sri Lanka (9.10%, p < 0.01). Angina-affected households significantly relied on borrowing or
selling assets to finance OOP health expenses in Bangladesh (6%, p = 0.03), India (8.20%, p < 0.01) and Sri Lanka
(7.80%, p = 0.01). However, impoverishment, non-medical consumption expenditure and employment status of the
angina-affected individual remained mostly unaffected. We adjusted our estimates for comorbidities, but limitations
on comorbidity data in the WHS mean that our results may be upwardly biased.
Conclusions: Households that had the respondent reporting angina in South Asia face an economic burden of
OOP health expenses (primarily on drugs and other outpatient expenses), and tend to rely on borrowing or selling
assets. Our analysis underscores the need to protect South Asian households from the financial burden of CVD.
Keywords: Symptomatic angina, Diagnosed angina, OOP health spending, Catastrophic expenses, Borrowing or
selling assets, Employment status, Non-medical consumption expenditure, Households, South AsiaBackground
The World Health Organization (WHO) estimates that
54 million people live with angina pectoris globally, of
whom 16 million are from the WHO South-East Asia
region. Angina pectoris (or angina) is a chest pain or dis-
comfort that occurs due to lack of oxygen-rich blood in* Correspondence: khurshid.alam@monash.edu
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distribution, and reproduction in any mediumone’s heart muscle [1]. Studies have shown that angina is
strongly associated with ischemic heart disease (IHD)
that occurs due to obstruction of the coronary arteries [2].
In 2008, nearly 80% of deaths from non-communicable
diseases (NCDs) occurred in low-and middle-income
countries (LMICs), caused mostly by IHD [3]. Even
though angina itself is not a severe health condition like
heart attack, people affected by angina will typically need
treatment and prevention to avoid further worsening
of their health and associated economic consequences.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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medication, including beta blockers, angiotensin convert-
ing enzyme inhibitors and blood thinning drugs may
be required. Because angina often reflects build-up of
plaque in blood vessels, it may also necessitate surgical
procedures such as angioplasty and cardiac bypass surgery
which can be expensive.
The health burden of heart disease in LMICs is acquiring
increasing significance [4-6], although the associated
economic implications are only recently being appreci-
ated. One study for India showed that out-of-pocket
(OOP) payments for hospital care associated with car-
diovascular disease (CVD) amounted to almost 30% of
annual expenditures among households to which pa-
tients belonged [7]. Another study for LMICs showed
that OOP expenses for hospital care for CVD exceeded
the catastrophic threshold (defined as 40% of non-food
expenditure) in 50% of the hospitalized cases in India,
China, and Tanzania [8]. However, these analyses focus
on hospitalized cases, usually arising from heart attacks.
Analyses of the economic consequences of angina on
households are relatively scarce in LMICs. Research using
World Health Survey (WHS) data for Bangladesh, India,
Nepal, Sri Lanka, and Ukraine showed that angina im-
posed significant OOP health expenditures particularly,
for drugs, on households [9,10]. In a developed country
context, studies from the United States show that angina
exerts major effects on health related quality of life affect-
ing individual’s working ability [11], and chronic angina is
associated with significant healthcare costs [12]. In South
Asia, where the burden of CVD is likely to rise sharply
in future years, an assessment of the economic burden
of angina can help in the design of effective policies.
This study seeks to assess the economic burden of angina
on households in South Asia, specifically in Bangladesh,
India, Nepal and Sri Lanka. The focus on South Asia is
driven by the fact that NCDs (particularly heart disease)
have attracted much attention as a major source of death
and disability in South Asia. In addition, the authors
are well informed about the health system contexts in
the South Asian region and are in position to make an
informed assessment of the ongoing challenges of health
financing and delivery in the region.
Methods
Data source
The WHS is a set of nationally representative household
surveys conducted by the WHO that collected observa-
tional data on socioeconomic and demographic characteris-
tics of individuals and households, healthcare financing
and healthcare use in 70 low, middle and high income
countries during 2002-2003. The WHS data also included
disease specific information from one adult member
(randomly chosen using Kish Tables) in each household,aged 18 years or over. Sample households were selected
based on a random, stratified sampling procedure. The
sampling procedure is described in detail elsewhere [13].
The interviews were conducted in person following written
consent from the respondent and institutional ethical ap-
proval for the survey at each study site. The Monash
University Human Research Ethics Committee granted
exemption from further ethical review (reference no.
CF12/1442-2012000778). Our study included WHS data
from four South Asian countries: Bangladesh (5,942 house-
holds), India (10,692 households), Nepal (8,822 households)
and Sri Lanka (6,805 households), consisting of 32,261
households in total. We could not include WHS data from
Pakistan because of the small number of angina cases.
Propensity score matching approach
Our analysis inquired whether households where a re-
spondent reported angina (angina-affected households)
experienced different economic outcomes than households
that did not. Because the angina variable can be expected
to be non-randomly allocated across respondents, we
sought to control for household (and individual respondent)
characteristics in undertaking this comparison, using
the propensity score matching (PSM) approach [14]. Using
PSM, we examined whether OOP health spending, ex-
penditure on drugs and hospitalization, employment and
non-medical consumption spending in angina-affected
households were different from those of control house-
holds. We assessed whether angina-affected house-
holds had higher levels of catastrophic OOP spending
and medical impoverishment and whether they relied
more on borrowing or selling assets for financing OOP
health spending than control households.
PSM comprises a two-stage process: in first stage,
propensity scores for the treated and control samples
are estimated using pre-treatment covariates in a logit
model. In the second stage, angina-affected households
are matched to control households with similar propensity
scores using a matching algorithm. For balance checking,
for each covariate used in the regression model that
generated the propensity scores, we compared the means
between the angina-affected households and matched
control households using t-test. We performed analysis
using STATA, version 12.1.
Measurement of treatment variable
We considered three versions of the angina (treatment)
variable:
Diagnosed angina
Households that had the respondent reporting diagnosed
angina were included as ‘treated’ cases and those who did
not were taken as ‘control’ cases. Diagnosed angina was
defined by affirmative response to the question: “Have you
Alam and Mahal BMC Public Health 2014, 14:179 Page 3 of 12
http://www.biomedcentral.com/1471-2458/14/179ever been diagnosed with angina or angina pectoris
(a heart disease)?” The estimated prevalence of diagnosed
angina reported in WHS was 6.58% in Bangladesh, 7.27%
in India, 5.45% in Nepal and 2.81% in Sri Lanka.
Symptomatic angina
Symptomatic angina was determined on the basis of ques-
tions in WHS following the Rose questionnaire [15,16]. Re-
spondents reporting affirmatively to questions about pain
and discomfort in the chest when walking; slowing down or
stopping when getting pain/discomfort to relieve the pain
or taking pain relief medicines; location of the chest pain or
discomfort is in the upper middle chest, or lower chest and
left arm of the body were determined as having angina.
Households that had the respondent reporting these symp-
toms were included as ‘treated’ cases with the rest as ‘con-
trol’ cases. The estimated prevalence of symptomatic angina
reported in WHS was 10.34% in Bangladesh, 10.89% in
India, 4.39% in Nepal and 3.66% in Sri Lanka.
Symptomatic or diagnosed angina
We constructed our third treatment variable where house-
holds that had the respondent reporting either symptom-
atic or diagnosed angina were included as ‘treated’ cases
and those who did not were taken as ‘control’ cases. The
estimated prevalence of symptomatic or diagnosed angina
reported in WHS was 14.98% in Bangladesh, 16.03% in
India, 9.31% in Nepal and 6.11% in Sri Lanka. The correl-
ation coefficient for symptomatic and diagnosed angina
was 0.17 in Bangladesh, 0.17 in India, 0.06 in Nepal and
0.19 in Sri Lanka.
Matching variables used to construct propensity scores
Individual respondent characteristics
We used age (complete years), indicator of sex (1 if re-
spondent was female, 0 otherwise), indicator of marital
status (1 if respondent is currently married or cohabitating,
0 otherwise) and multiple indicators for education of the
respondent (1 if primary school completed, 0 otherwise; 1 if
secondary school completed, 0 otherwise; 1 if high school
completed, 0 otherwise; and 1 if college completed, 0 other-
wise). Using information on the most commonly spoken
language for each country, we constructed a binary language
variable (1 if the respondent spoke that language, 0 other-
wise (in Bangladesh Bangla, in India Hindi, in Nepal Nepali
and in Sri Lanka Sinhala)). Similarly, using information on
majority religious ethnic groups, we constructed a binary
indicator of religion (1 if the respondent belonged to the
majority religion, 0 otherwise (in Bangladesh Muslim, in
India Hindu, in Nepal Hindu, and in Sri Lanka Sinhalese)).
Other household members
Socioeconomic and demographic characteristics were used
for all household members other than the respondent.These included, specifically, the proportion of females
in the household, the proportion of currently married
members including those cohabiting in the household,
the proportion of children under-five years of age, the
proportion of adults (18-59 years), the proportion of elderly
(60 years and above) members, and the proportion of mem-
bers who had completed high school or above. In addition,
we used age of the head of household (completed years);
indicator of sex of household head (1 if male, 0 otherwise);
indicator of marital status of household head (1 if currently
married or cohabitating, 0 otherwise); and indicator of
education of the household head (1 if completed high
school or above, 0 otherwise).
Other household characteristics
These included household size, household sample weights,
rural-urban indicator (1 if urban, 0 otherwise) and indica-
tors for sampling strata (1 if the household was located
within the appropriate stratum, 0 otherwise) used to stratify
households regionally for sampling purposes. There
were 12 strata in Bangladesh, 12 in India, 71 in Nepal
and 33 in Sri Lanka. Multiple indicators for living condi-
tions were also used: improved drinking water sources
(1 if the household had access to water from piped sources,
protected tube well or bore hole, or protected dug well or
protected spring, rainwater, or tanker-truck, 0 otherwise)
and improved toilets (1 if the household has toilet facilities
with flush or piped sewage system, or flush to septic tank,
or poor flush latrine, 0 otherwise) [17]; clean cooking fuel
(1 if the household used gas or electricity for cooking,
0 otherwise); improved cooking stove (1 if the household
used open fire/stove with chimney or hood, or closed
stove with chimney, 0 otherwise); separate space for cook-
ing (1 if the household had separate location as kitchen, 0
otherwise); heating conditions (1 if the household had
heating system during cold weather, 0 otherwise); floor
type (1 if the floor of the household was hard floor such
as tile, cement, brick or wood, 0 otherwise); and wall type
(1 if the wall of the household residence was cement, brick,
stone or wood, 0 otherwise).
A rudimentary social capital variable (as a proxy for social
network) was also constructed based on survey responses
to 10 questions in WHS data. First, indicator variables were
constructed on respondents’ ability to control important
things in life (1 if never or almost never, 0 otherwise);
on ability to cope with their responsibilities (1 if never
or almost never, 0 otherwise); level of trust in national
government (1 if always or most of the time, 0 otherwise);
level of trust in local government (1 if always or most of the
time, 0 otherwise); feeling safe from crime and violence
at home (1 if completely safe or very safe, 0 otherwise);
or outside (1 if completely safe or very safe, 0 otherwise);
on ability to influence government to address issues of
interest (1 if unlimited or a lot of say, 0 otherwise); freedom
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voting behaviour in last national election (1 if voted,
0 otherwise); and on being a victim of violent crime
(1 if yes, 0 otherwise). Second, a social capital variable
was constructed from the 10 indicators based on prin-
cipal component factor analysis. Social capital posi-
tively influences household economic outcomes such




The WHS reported OOP health spending in the four
weeks preceding the survey in two ways - one as a single
estimate and another in itemized form, with health ex-
penditures separately reported for inpatient care, out-
patient care, traditional or alternative sources of care,
dentists, medication, healthcare products, laboratory
services and others [19]. Single item questions tend to
generate significantly lower aggregate expenditures than
the sum of multiple disaggregated questions [20,21]. For
this reason, and also because of our interest in individ-
ual components of OOP spending, we used the sum of
item-wise reports of health spending divided by house-
hold size (that is, per household member).
Spending on drugs
Our measure was OOP spending on drugs per person in
the household in the four weeks preceding the survey.
Spending on hospitalization
We used household OOP spending on hospitalization
expenditure (per member) in the four weeks preceding
the survey.
Reliance on borrowing or sale of assets to finance
health expenditure
The WHS collected information on financing strategies
that households used to meet health expenditures in one
year preceding the survey [19]. We constructed a binary
outcome indicator taking the value 1 if any household
reported borrowing from a family or friend or from outside
the household, or reporting selling of household items to
pay for healthcare, 0 otherwise.
Measure of catastrophic OOP health spending
We constructed two measures of catastrophic OOP
health spending: an indicator variable that took the value
1 whenever the ratio of household OOP health spending
to total expenditure exceeded 20% [22]; and an indicator
variable that took the value 1 when the ratio of household
OOP health spending to a measure of household’s ‘cap-
acity to pay’ (total expenditure minus subsistence needs)exceeded 40% [23]. A household’s ‘capacity to pay’ (CTP)
was calculated in the following way:
CTP ¼ TEX−SE 45−55ð Þ If FEX > SE 45−55ð Þ
CTP ¼ TEX−FEX FEX If FEX < SE 45−55ð Þ
TEX denotes total expenditure and FEX denotes food
expenditure. SE stands for subsistence expenditure and is
the average food expenditure for households whose food
expenditure share of total expenditure is in the 45th to 55th
percentile of the total sample of households, adjusted for
household size. Household consumption equivalence scales
were used rather than the actual household size [23].
Impoverishing effect of OOP health spending
Following Wagstaff and van Doorslaer (2003), a household
was defined as being impoverished due to illness if its total
spending gross of OOP on healthcare exceeded the poverty
line, but total spending net of OOP on healthcare was
below the poverty line [24]. We used World Bank’s pur-
chasing power parity (PPP) based international poverty
line for low-income countries for this purpose, defined
as 1.25 international dollars per day per person.
Employment
Two indicators for employment status of angina-affected
respondent were used. The first was based on whether
the respondent was currently working (1 if the respondent
was government employee, or non-government employee,
or self-employed, or employer, 0 otherwise). The second
indicator inquired above the main reason for not working
for pay (1 if the respondent was not working due to illness,
0 otherwise).
Non-medical consumption expenditure
The WHS data recorded household consumption spending
in four weeks preceding the survey in two ways: one as a
single aggregate measure and another in itemized form
such as food, housing, education, insurance premiums
and all other goods [19]. We constructed a measure of
non-medical consumption of households by summing
up itemized expenditures, excluding medical spending.
All expenditure estimates are reported in international
dollar (I$) based on the World Banks’s PPP in 2003.
Robustness checks
We used multiple matching algorithms – nearest-neighbor,
stratification, radius and kernel matching – to compare
outcomes for angina-affected households and controls.
There is also the possibility that our matching results
could be confounded by comorbidities, which can in-
clude diabetes, asthma, depression, anemia, arrhythmia
(tachycardia), chronic obstructive pulmonary disease,
heart failure, hyperthyroidism and renal failure [25-28].
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regression models (with economic outcomes as the Y
variables), an indicator for angina-affected households
and an indicator for presence of a comorbid condition
(at least one of diabetes, asthma, and depression for
which information was available in the WHS dataset) on
a dataset consisting only of matched households.
Results
Table 1 presents summary statistics for the key variables
included in the first-stage (propensity score) regression, for
(treatment) households that had the respondent reporting
symptomatic or diagnosed angina and the subset of
matched households (based on nearest-neighbor matching)
that had respondents not reporting symptomatic or di-
agnosed angina. There were no statistically significant
differences between treatment households and matched
controls (based on nearest-neighbor matching) on age, sex,
marital status and education level of the angina-affected
individual, other household members, household head
and basic household characteristics within any of the
four South Asian countries. Although not presented in
Table 1, separate analyses for matching involving diagnosed
angina (only) as treatment, and symptomatic angina (only)
as treatment did not indicate statistically different values
between the pre-treatment covariates for treatment and
control households.
We did, however, find statistically significant differences
in economic outcomes between households that had a re-
spondent reporting symptomatic or diagnosed angina and
their matched controls. Table 2 reports these findings for
the nearest-neighbor matching method. Per person OOP
health spending was generally higher in households that
had the respondent reporting symptomatic or diagnosed
angina relative to matched controls across all four South
Asian countries we studied, and this difference was sta-
tistically significant in Bangladesh (I$8.80 versus I$6.86,
p = 0.04), Nepal (I$9.65 versus I$4.97, p = 0.03) and Sri
Lanka (I$4.22 versus I$2.23, p < 0.01). Nearly half of this
difference was accounted for by drug expenditures which
were significantly higher in Nepal (I$6.71 versus I$3.27,
p = 0.01) and Sri Lanka (I$1.94 versus I$1.00, p < 0.01),
relative to the matched control group. Per person OOP
hospitalization expenditure was significantly (p = 0.05)
different between the treated and control groups only in
Sri Lanka. Our data also indicate that the proportion of
households reporting borrowing or sale of assets to fi-
nance their OOP health spending was between 4%-8%
higher in treatment households relative to matched con-
trols in all four countries, and only in Nepal were the
differences not statistically significant at 5% level. In Sri
Lanka, the proportion of treatment households report-
ing borrowing or sale of assets was, at 21%, the lowest
among the four countries studied.The share of households reporting catastrophic health
spending was higher in treatment households compared
to matched controls by 3%-10% in all countries, but
statistical significance was not always achieved. When
catastrophic spending was defined as OOP health
spending exceeding 20% of total household expenditure,
it was significantly higher in angina-affected households
(relative to matched controls) in India (28.26% versus
18.69%, p < 0.01), Nepal (18.26% versus 13.40%, p = 0.02)
and Sri Lanka (13.44% versus 4.37%, p < 0.01); although
lower in absolute magnitude, the results were in the same
direction when catastrophic spending was instead defined
as the ratio of OOP health spending to household’s
‘capacity to pay’ in excess of 40%, also in the same set of
countries. We also used the ratio OOP health spending to
total household expenditure and the ratio of OOP drug ex-
penditures to total household expenditure as outcome mea-
sures. Here again, the differences between angina-affected
households and matched control households were signifi-
cantly higher, ranging from 2%-4% for the OOP spending
to total household expenditure, and 1%-2% for the ratio of
OOP spending on drugs to total household expenditure.
Angina-affected households also reported higher levels of
impoverishment due to OOP spending relative to matched
controls (with the difference ranging from 0.80% to 3.50%
of households), although the difference was statistically
significant (p = 0.03) only in Sri Lanka. Employment of the
angina-affected individual was generally lower compared
to their matched counterparts in most South Asian coun-
tries; however, none of the differences were statistically
significant at the 5% level. Because there could be a number
of reasons for why people are working (or not), particularly
women who have lower workforce participation rates, we
also considered an alternative outcome measure: whether a
person reported not working due to illness. Generally, the
share of respondents not working due to illness were higher
among those reporting angina, relative to matched counter-
parts in all four countries, by 1.50% to 4.70% and these
differences were statistically significant (at 5% level) in
Bangladesh and Sri Lanka; and Nepal at the 10% level of
significance. Differences in per person non-medical con-
sumption expenditure between angina-affected and control
households were statistically indistinguishable from zero in
Bangladesh, India and Sri Lanka. In Nepal, however, non-
medical consumption expenditure was actually higher in
angina-affected households relative to matched controls
(I$47.65 versus I$42.41, p = 0.04).
Table 3 reports our results for three alternative indicators
of angina-affected (treatment) households –diagnosed with
angina, having symptoms of angina, and having either of
the two. The set of treatment and matched control house-
holds differs for the three indicators so the estimates of the
economic burden are not directly comparable across the
different angina definitions. Nonetheless, there are some
Table 1 Summary of key matching variables by symptomatic or diagnosed angina-affected and control households in South Asia, 2002-2003
Matching variables Bangladesh India Nepal Sri Lanka
Treated Controls-matched Treated Controls-matched Treated Controls-matched Treated Controls-matched
Angina-affected individual
Age (mean) 42.30 (41.17, 43.43) 42.31 (41.03, 43.59) 43.03 (42.11, 43.95) 43.37 (42.34, 44.40) 45.19 (43.94, 46.44) 44.50 (43.16, 45.84) 44.96 (43.32, 46.60) 45.73 (43.84, 47.62)
Sex: female (%) 61.28 (57.76, 64.80) 62.91 (59.12, 66.70) 57.07 (54.17, 59.97) 56.35 (53.06, 59.64) 57.96 (54.00, 61.92) 58.12 (53.97, 62.27) 54.37 (48.91, 59.83) 52.19 (46.21, 58.17)
Education level: high school
and above (%)
3.40 (2.09, 4.71) 3.12 (1.76, 4.48) 5.28 (3.97, 6.59) 5.99 (4.41, 7.57) 3.01 (1.64, 4.38) 3.01 (1.57, 4.45) 6.25 (3.60, 8.90) 6.87 (3.84, 9.90)
Marital status: currently married (%) 78.40 (75.43, 81.37) 80.03 (76.89, 83.17) 80.59 (78.27, 82.91) 80.23 (77.59, 82.87) 87.44 (84.78, 90.10) 88.78 (86.13, 91.43) 75.94 (71.26, 80.62) 78.12 (73.17, 83.07)
Other non-angina
household members
Children under-five years of age (%) 13.08 (10.64,15.52) 12.68 (10.07, 15.29) 9.10 (7.41, 10.79) 9.28 (7.35, 11.21) 11.92 (9.32, 14.52) 12.54 (9.75, 15.33) 8.01 (5.04, 10.98) 8.71 (5.33, 12.09)
Adult members (%) 39.89 (36.35, 43.43) 39.34 (35.51, 43.17) 40.20 (37.33, 43.07) 40.22 (36.97, 43.47) 37.77 (33.88, 41.66) 36.62 (32.57, 40.67) 48.54 (43.06, 54.02) 48.41 (42.43, 54.39)
Elderly members (%) 7.93 (5.98, 9.88) 8.11 (5.97, 10.25) 18.28 (16.01, 20.55) 17.29 (14.78, 19.80) 8.58 (6.33, 10.83) 8.71 (6.34, 11.08) 9.18 (6.02, 12.34) 9.52 (6.01, 13.03)
Sex: female (%) 46.96 (43.35, 50.57) 47.80 (43.88, 51.72) 52.59 (49.66, 55.52) 52.40 (49.09, 55.71) 50.76 (46.75, 54.77) 50.47 (46.26, 54.68) 48.21 (42.74, 53.68) 48.56 (42.58, 54.54)
Education level: high school
and above (%)
6.93 (5.10, 8.76) 6.66 (4.70, 8.62) 14.85 (12.77, 16.93) 14.76 (12.41, 17.11) 5.69 (3.83, 7.55) 5.53 (3.61, 7.45) 18.75 (14.47, 23.03) 20.94 (16.07, 25.81)
Marital status: currently married (%) 36.71 (33.23, 40.19) 36.97 (33.18, 40.76) 37.10 (34.27, 39.93) 37.10 (33.89, 40.31) 37.99 (34.10, 41.88) 37.42 (33.35, 41.49) 34.87 (29.65, 40.09) 36.13 (30.38, 41.88)
Characteristics of household head
Age (mean) 43.31 (42.24, 44.38) 42.69 (41.58, 43.80) 45.52 (44.69, 46.35) 45.58 (44.61, 46.55) 46.10 (44.94, 47.26) 45.97 (44.70, 47.24) 48.89 (47.32, 50.46) 49.68 (47.86, 51.5)
Sex: male-headed household (%) 88.72 (86.43, 91.01) 86.68 (84.01, 89.35) 91.23 (89.57, 92.89) 92.04 (90.24, 93.84) 83.42 (80.44, 86.4) 84.25 (81.19, 87.31) 80.62 (76.29, 84.95) 80.62 (75.89, 85.35)
Education level: high school
and above (%)
5.43 (3.79, 7.07) 5.03 (3.32, 6.74) 6.26 (4.84, 7.68) 5.99 (4.41, 7.57) 3.35 (1.91, 4.79) 3.01 (1.57, 4.45) 4.37 (2.13, 6.61) 5.31 (2.63, 7.99)
Marital status: currently married (%) 85.60 (83.06, 88.14) 85.73 (82.99, 88.47) 85.96 (83.92, 88.00) 86.94 (84.70, 89.18) 90.28 (87.90, 92.66) 91.12 (88.73, 93.51) 80.94 (76.64, 85.24) 82.50 (77.95, 87.05)
Characteristics of household
Household size (mean) 5.56 (5.40, 5.72) 5.40 (5.23, 5.57) 6.27 (6.12, 6.42) 6.32 (6.16, 6.48) 5.37 (5.18, 5.56) 5.37 (5.20, 5.54) 4.50 (4.30, 4.70) 4.51 (4.31, 4.71)
Location: urban (%) 21.19 (18.24, 24.14) 19.56 (16.45, 22.67) 14.40 (12.34, 16.46) 14.67 (12.32, 17.02) 10.89 (8.39, 13.39) 10.55 (7.97, 13.13) 14.37 (10.53, 18.21) 13.44 (9.36, 17.52)
Improved water source (%) 96.19 (94.81, 97.57) 96.19 (94.69, 97.69) 83.81 (81.65, 85.97) 83.54 (81.08, 86.00) 90.62 (88.28, 92.96) 92.63 (90.43, 94.83) 76.87 (72.25, 81.49) 74.06 (68.81, 79.31)
Improved latrine (%) 16.44 (13.76, 19.12) 15.35 (12.52, 18.18) 16.90 (14.70, 19.10) 17.44 (14.92, 19.96) 23.62 (20.21, 27.03) 21.94 (18.46, 25.42) 61.87 (56.55, 67.19) 61.87 (56.05, 67.69)
Clean cooking fuel (%) 0.81 (0.16, 1.46) 0.68 (0.04, 1.32) 2.59 (1.66, 3.52) 3.13 (1.97, 4.29) 1.67 (0.64, 2.70) 1.67 (0.59, 2.75) 0.31 (-0.30, 0.92) 0.00 (0.00, 0.00)
Improved cooking stove (%) 1.90 (0.91, 2.89) 2.72 (1.44, 4.00) 16.90 (14.70, 19.10) 19.14 (16.53, 21.75) 6.87 (4.84, 8.90) 8.37 (6.04, 10.70) 30.00 (24.98, 35.02) 34.69 (28.99, 40.39)
Sample 736 624 1118 872 597 543 320 268
Notes: Un-weighted estimates are based on authors’ calculations using raw data from the World Health Survey conducted during 2002-2003. The data presented refer to the households, which responded to the survey
question on whether or not a household member experienced any angina which includes diagnosed or symptomatic angina. 95% confidence intervals are reported in parentheses underneath each mean/proportion.





















Table 2 Differences in economic outcomes between symptomatic or diagnosed angina-affected households and control households in South Asia, 2002-2003
Economic outcome
indicators
Bangladesh India Nepal Sri Lanka
Treated Controls-matched p-value Treated Controls-matched p-value Treated Controls-matched p-value Treated Controls-matched p-value
Per person OOP health
spending in last four
weeks (I$)
8.80 (7.39, 10.21) 6.86 (5.76, 7.96) 0.04* 8.25 (6.94, 9.56) 6.80 (5.00, 8.60) 0.25 9.65 (5.79, 13.51) 4.97 (3.59, 6.35) 0.03* 4.22 (3.16, 5.28) 2.23 (1.42, 3.04) <0.01*
Per person expenditure
on medicine in last four
weeks (I$)
5.40 (4.77, 6.03) 4.60 (3.80, 5.40) 0.16 4.31 (3.30, 5.32) 3.45 (2.40, 4.50) 0.30 6.71 (4.16, 9.26) 3.27 (2.57, 3.97) 0.01* 1.94 (1.46, 2.42) 1.00 (0.68, 1.32) <0.01*
Per person hospitalization
expenses in last four
weeks (I$)
0.96 (-0.01, 1.93) 0.24 (0.04, 0.44) 0.16 1.44 (0.87, 2.01) 1.66 (0.35, 2.97) 0.80 1.16 (0.15, 2.17) 0.46 (-0.01, 0.93) 0.22 0.92 (0.22, 1.62) 0.18 (-0.04, 0.40) 0.05*
Borrowing or selling
assets to finance health
expenditure in last one
year (%)
46.06 (42.46, 49.66) 40.08 (36.23, 43.93) 0.03* 51.79 (48.86, 54.72) 43.56 (40.27, 46.85) <0.01* 57.62 (53.66, 61.58) 53.60 (49.41, 57.79) 0.18 21.25 (16.77, 25.73) 13.44 (9.36, 17.52) 0.01*
OOP health spending
share of total household
expenditure at 20%
cut-off
28.40 (25.14, 31.66) 24.59 (21.21, 27.97) 0.13 28.26 (25.62, 30.9) 18.69 (16.10, 21.28) <0.01* 18.26 (15.16, 21.36) 13.40 (10.53, 16.27) 0.02* 13.44 (9.70, 17.18) 4.37 (1.92, 6.82) <0.01*
OOP health spending
share of household’s
‘capacity to pay’ at
40% cut-off
39.40 (35.87, 42.93) 35.87 (32.11, 39.63) 0.20 33.00 (30.24, 35.76) 26.30 (23.38, 29.22) <0.01* 21.27 (17.99, 24.55) 16.75 (13.61, 19.89) 0.05* 21.87 (17.34, 26.40) 11.87 (8.00, 15.74) <0.01*




15.73 (13.10, 18.36) 13.75 (11.05, 16.45) 0.02* 15.10 (13.00, 17.20) 11.52 (9.40, 13.64) <0.01* 9.86 (7.47, 12.25) 7.61 (5.38, 9.84) 0.01* 7.91 (4.95, 10.87) 4.49 (2.01, 6.97) <0.01*




11.28 (8.99, 13.57) 10.07 (7.71, 12.43) 0.05* 8.62 (6.97, 10.27) 6.89 (5.21, 8.57) <0.01* 7.97 (5.80, 10.14) 5.84 (3.87, 7.81) <0.01* 3.96 (1.82, 6.10) 2.19 (0.44, 3.94) <0.01*
Impoverishment due to
OOP health payments (%)




40.76 (37.21, 44.31) 38.45 (34.63, 42.27) 0.41 55.10 (52.18, 58.02) 56.08 (52.79, 59.37) 0.68 67.50 (63.74, 71.26) 70.52 (66.68, 74.36) 0.28 39.69 (34.33, 45.05) 40.62 (34.74, 46.5) 0.83
Unemployed due to
illness (%)
2.72 (1.54, 3.90) 0.27 (-0.14, 0.68) <0.01* 5.81 (4.44, 7.18) 4.29 (2.95, 5.63) 0.14 4.86 (3.14, 6.58) 2.85 (1.45, 4.25) 0.07 8.12 (5.13, 11.11) 3.44 (1.26, 5.62) 0.02*
Per person non-medical
consumption
expenditure in last four
weeks (I$)
46.78 (36.51, 57.05) 39.81 (33.24, 46.38) 0.25 34.02 (30.95, 37.09) 37.30 (29.12, 45.48) 0.42 47.65 (43.69, 51.61) 42.41 (39.60, 45.22) 0.04* 37.72 (35.46, 39.98) 40.60 (37.43, 43.77) 0.18
Sample 736 624 - 1118 872 - 597 543 - 320 268 -
Notes: Un-weighted estimates are based on authors’ calculations using raw data from the World Health Survey conducted during 2002-2003 and using nearest-neighbor matching. The data presented refer to the households, which
responded to the survey question on whether or not a household member experienced any angina which includes diagnosed or symptomatic angina. 95% confidence intervals are reported in parentheses underneath each mean/
proportion. Considering the sample used in the nearest-neighbor matching statistically significant difference between the treatment and matched controls are shown at the significance level of 5%*. All expenditure estimates are in





















Table 3 Differences in economic outcomes between angina-affected households and control households in South Asia, 2002-2003: Results for different
definitions of angina-affected household

























Per person OOP health
spending in last four weeks (I$)
1.94* (0.04) 1.50 (0.15) 0.49 (0.75) 1.45 (0.25) 1.25 (0.32) 4.91* (<0.01) 4.68* (0.03) 4.14 (0.12) 2.61 (0.65) 1.99* (<0.01) 4.47 (0.18) 5.23 (0.15)
Per person expenditure on
medicine in last four weeks (I$)
0.80 (0.16) 0.66 (0.23) 0.70 (0.23) 0.87 (0.30) 0.77 (0.36) 1.99 (0.08) 3.45* (0.01) 3.59 (0.12) 0.52 (0.89) 0.94* (<0.01) 0.22 (0.61) 0.92* (0.04)
Per person hospitalization
expenses in last four weeks (I$)
0.72 (0.16) 0.56 (0.37) -0.45 (0.71) -0.21 (0.80) -0.20 (0.79) 1.51* (0.01) 0.70 (0.22) 0.53 (0.28) 0.16 (0.92) 0.74* (0.05) 3.66 (0.27) 4.46 (0.22)
Borrowing or selling assets to
finance health expenditure in
last one year (%)
6.00* (0.03) 2.20 (0.53) 0.90 (0.82) 8.20* (<0.01) 6.40* (0.02) 9.70* (<0.01) 4.00 (0.18) 8.80* (0.04) 1.80 (0.65) 7.80* (0.01) 10.40* (0.01) 7.70 (0.10)
OOP health spending share of
total household expenditure at
20% cut-off (%)
3.80 (0.13) <0.01 (1.00) 1.80 (0.63) 9.60* (<0.01) 2.50 (0.28) 13.30* (<0.01) 4.90* (0.02) 7.50* (0.01) 5.80* (0.04) 9.10* (<0.01) 3.30 (0.31) 9.50* (<0.01)
OOP health spending share of
household’s ‘capacity to pay’ at
40% cut-off (%)
3.50 (0.20) 2.00 (0.56) -1.80 (0.65) 6.70* (<0.01) 0.60 (0.80) 10.10* (<0.01) 4.50* (0.05) 8.40* (<0.01) 7.00* (0.02) 10.00* (<0.01) 8.20* (0.05) 8.90* (0.04)
Ratio of OOP health spending
and total household
expenditure (%)
2.00* (0.02) 0.40 (0.70) 1.10 (0.32) 3.60* (<0.01) 1.40 (0.15) 5.40* (<0.01) 2.20* (0.01) 4.00* (<0.01) 3.70* (<0.01) 3.40* (<0.01) 2.10 (0.08) 3.30* (<0.01)
Ratio of OOP medicine
expenses and total household
expenditure (%)
1.20* (0.05) 0.40 (0.59) 0.40 (0.60) 1.70* (<0.01) 0.40 (0.61) 2.00* (0.02) 2.10* (<0.01) 3.70* (<0.01) 2.70* (<0.01) 1.80* (<0.01) 0.30 (0.68) 2.00* (<0.01)
Impoverishment due to OOP
health payments (%)




2.30 (0.41) 1.50 (0.65) -1.50 (0.71) -1.00 (0.68) 3.50 (0.19) -3.00 (0.37) -3.00 (0.28) 1.90 (0.62) -1.50 (0.68) -0.90 (0.83) -5.50 (0.30) -1.80 (0.76)
Unemployed due to illness (%) 2.40* (<0.01) 1.50 (0.08) 2.90* (0.01) 1.50 (0.14) 0.50 (0.65) 3.20* (0.02) 2.00 (0.07) 2.60 (0.11) 1.50 (0.29) 4.70* (0.02) 7.10* (<0.01) 5.30 (0.06)
Per person non-medical
consumption expenditure in
last four weeks (I$)
6.97 (0.25) -0.17 (0.97) 19.87 (0.07) -3.27 (0.42) 3.09 (0.09) 5.37 (0.07) 5.24* (0.04) -9.66 (0.28) 7.45* (0.04) -2.88 (0.18) -2.10 (0.49) -2.23 (0.39)
Treatment (control) 736 (624) 458 (414) 339 (308) 1118 (872) 793 (677) 503 (453) 597 (543) 308 (283) 328 (310) 320 (268) 183 (168) 169 (148)
Notes: Coefficients are the average treatment effects derived from the nearest-neighbor matching. For each coefficient statistical significant difference between the treatment and matched controls is shown at the level
of 5%*. Each p-value is reported in parenthesis below each estimate of the difference in outcomes between angina-affected and matched control households. All expenditure estimates are in international dollar based
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http://www.biomedcentral.com/1471-2458/14/179similarities in outcomes across the different angina indi-
cators. OOP spending overall and OOP spending on
drugs are higher in treatment households, relative to
matched controls, even if not always statistically signifi-
cant. The differences between angina-affected house-
holds and matched controls are sharper in many cases
(that is, become statistically different) when overall
OOP healthcare spending and OOP spending on drugs
are taken as a share of aggregate household spending.
Differences in catastrophic OOP spending are generally
significantly higher in angina-affected households rela-
tive to matched controls, with the exception of
Bangladesh where no differences were observed, similar
to results in Table 2; and with the exception of Sri
Lanka, no differences in medical impoverishment were
observed between angina-affected and matched control
households.
There were no differences in employment status of
angina-affected respondents between treatments and
matched control households in any country, irrespective
of the angina indicators used. However, unemployment
due to ill health was higher among respondents by about
1%-7%, with statistically significant differences between
treatment and matched control households in Sri Lanka
and Bangladesh.
Finally, household reliance on borrowing or sale of as-
sets to finance OOP healthcare spending was greater in
angina-affected households – by between 1% and 10% -
relative to matched controls, but the differences were
not always statistically significant. The largest differences
in borrowing or sale of assets among angina-affected
and control households were observed in India and Sri
Lanka, ranging between 6% and 10%. No discernible pat-
tern was visible in the estimates the outcomes across the
three different indicators of angina in Table 3.
Table 4 reports results based on regressions on
matched data using the nearest-neighbor matching, with
our outcomes variables as the Y variables, and as regres-
sors, an indicator for angina and an indicator for
whether the respondent had comorbidity associated with
CVD (diabetes or asthma or depression). The results in
Table 4 show that although many of the differences with
matched controls become lower and become statistically
insignificant in some cases, the direction of results and
our main conclusions are unchanged.
Discussion
Our analysis suggests that angina-affected households in
South Asia face a higher economic burden than similar
control households, based on propensity score compari-
sons. One aspect of this burden is OOP spending on
health services, primarily outpatient care and medicines.
Our analysis points to drug expenditures as a major
source of financial worry for the South Asian householdsthat have members with angina. Although OOP
hospitalization expenditures were not overall a signifi-
cant concern when considering the economic conse-
quences of angina in Bangladesh, India and Nepal; Sri
Lankan angina-affected households were an exception
and this may indicate greater awareness of ill-health and
reliance on healthcare use in Sri Lanka relative to its
South Asian neighbors [29,30].
Our analysis also points to a greater reliance on bor-
rowing or sale of assets to finance OOP healthcare by
angina-affected households relative to controls. This is
of concern since reliance on borrowing or sale of assets
can have long-term implications for the economic future
of household members if, for instance, there are high
costs of borrowing or if income-earning assets are sold.
The findings on borrowing or sale of assets may reflect
the limited nature of formal health insurance cover (or
good quality subsidized public services) available to pop-
ulations in South Asia [31]. Bangladesh and Nepal face
well known problems in access to public services or
other forms of insurance. The recent expansion of pub-
licly financed insurance cover in India has focused on
inpatient care [32], so angina-related OOP expenses will
continue to a source of concern to households in that
country. However, the relatively large effect of angina on
borrowing or sale of assets among households in Sri
Lanka affected by angina was a surprise, however, given
its highly subsidized public sector services. One explan-
ation for this finding is that much of the added expend-
iture for angina is for drugs for which Sri Lankans are
still likely to pay OOP payments [33]. Another is the in-
creasing role of private sector healthcare providers in Sri
Lanka, who are usually paid for OOP health payments
given the limited private insurance coverage for out-
patient services [34]. Nonetheless, it is noteworthy that
Sri Lankan households that have a member reporting di-
agnosed or symptom-based angina have the lowest rates
of borrowing or asset sales among the four countries in
the region (21%, compared to Bangladesh, India and
Nepal, where the rates range from 46% to 58%).
Previous studies have suggested that illness is associ-
ated with reduced labor supply and earnings [35-37].
Our results indicate that these effects are small for
respondents with angina - ranging from 1%-5% in
Bangladesh, India, Nepal and Sri Lanka. We suspect
these labor supply effects may be small, possibly because
the angina-affected individuals can continue their usual
work activities either because they need to, or because
they are simply unaware of their health status. In Sri
Lanka, unemployment due to illness is relatively larger,
of the order of 5%, relative to matched controls and this
again, may reflect higher levels of health awareness and
health seeking behavior in that country’s population. In-
deed, when we used diagnosed angina as the indicator,





























Per person OOP health
spending in last four weeks (I$)
1.55 (0.11) 1.46 (0.16) 0.18 (0.91) 0.73 (0.54) 0.39 (0.75) 4.42* (<0.01) 4.18 (0.06) 4.26 (0.14) 2.44 (0.67) 1.84* (0.01) 2.93 (0.42) 4.33 (0.27)
Per person expenditure on
medicine in last four weeks (I$)
0.38 (0.48) 0.64 (0.24) 0.42 (0.47) 0.35 (0.66) 0.22 (0.80) 1.73 (0.16) 3.19* (0.03) 3.34 (0.19) 0.56 (0.88) 0.86* (<0.01) 0.05 ( 0.90) 0.89* (0.05)
Per person hospitalization
expenses in last four weeks (I$)
0.80 (0.15) 0.61 (0.35) -0.33 (0.78) -0.05 (0.95) -0.45 (0.52) 1.55* (0.02) 0.68 (0.26) 0.84 (0.13) 0.20 (0.91) 0.77 (0.07) 2.28 (0.53) 3.71 (0.34)
Borrowing or selling assets to
finance health expenditure in
last one year (%)
3.45 (0.21) 1.92 (0.57) -0.77 (0.85) 4.94* (0.03) 3.30 (0.21) 3.87 (0.25) 3.05 (0.31) 9.20* (0.03) 0.40 (0.92) 8.58* (<0.01) 10.51* (0.01) 6.75 (0.14)
OOP health spending share
of total household expenditure
at 20% cut-off (%)
2.87 (0.24) -1.44 (0.63) -0.27 (0.94) 6.34* (<0.01) 2.29 (0.32) 11.26* (<0.01) 5.36* (0.01) 8.37* (<0.01) 4.83 (0.09) 8.50* (<0.01) 4.98 (0.14) 8.58* (<0.01)
OOP health spending share of
household’s ‘capacity to pay’ at
40% cut-off (%)
2.94 (0.28) 0.49 (0.88) -4.78 (0.22) 3.51 (0.11) -0.24 (0.92) 8.20* (<0.01) 5.08* (0.03) 9.59* (<0.01) 6.51* (0.03) 11.09* (<0.01) 9.85* (0.02) 8.46* (0.05)
Ratio of OOP health spending
and total household
expenditure (%)
1.47 (0.07) 0.18 (0.85) 0.43 (0.70) 2.27* (<0.01) 0.91 (0.34) 4.41* (<0.01) 2.22* (0.01) 3.75* (<0.01) 3.32* (<0.01) 3.27* (<0.01) 2.29 (0.06) 2.99* (0.01)
Ratio of OOP medicine
expenses and total household
expenditure (%)
0.76 (0.22) 0.29 (0.70) 0.04 (0.96) 1.00 (0.11) -0.03 (0.97) 1.77 (0.06) 2.12* (<0.01) 3.45* (0.01) 2.34* (0.01) 1.63* (<0.01) 0.07 (0.92) 1.93* (0.01)
Impoverishment due to OOP
health payments (%)
1.13 (0.53) -3.47 (0.12) 1.83 (0.52) 0.93 (0.50) 0.46 (0.77) -0.78 (0.72) 1.95 (0.22) 1.89 (0.42) 2.04 (0.28) 3.01 (0.07) 2.32 (0.26) 4.77* (0.03)
Employment status of
angina-affected individual (%)
2.06 (0.45) 0.52 (0.88) 0.78 (0.85) -1.29 (0.58) 2.82 (0.29) -0.83 (0.80) -1.00 (0.72) 2.51 (0.54) 0.54 (0.88) 0.62 (0.88) -4.04 (0.45) 1.03 (0.85)
Unemployed due to illness (%) 1.93* (<0.01) 1.13 (0.20) 2.21 (0.08) 0.40 (0.70) -0.06 (0.95) 2.70 (0.07) 2.03 (0.08) 1.70 (0.32) 1.14 (0.44) 3.31 (0.10) 3.91 (0.15) 4.34 (0.13)
Per person non-medical
consumption expenditure in
last four weeks (I$)
7.60 (0.24) 1.47 (0.72) 19.27 (0.10) -2.76 (0.45) 1.65 (0.38) 2.77 (0.39) 5.59* (0.03) -15.27 (0.08) 7.47* (0.04) -4.67 (0.02)* -2.84 (0.35) -2.82 (0.26)
Sample 1360 872 647 1990 1470 956 1140 591 638 588 351 317
Notes: Regression coefficients are derived using data sets consisting of only matched households using the nearest-neighbor method and coefficients are controlled for co-morbid conditions such as diabetes, asthma
and depression. Each p-value is in parenthesis. For each coefficient statistical significance is shown at the level of 5%*. All expenditure estimates are in international dollar based on the World Banks’s purchasing power
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http://www.biomedcentral.com/1471-2458/14/179we also found that unemployment due to illness increased
among respondents in Bangladesh, India, Nepal and Sri
Lanka, relative to matched controls.
Illness is likely to be associated with changes in non-
medical consumption of low-income households, although
not all analyses reach this conclusion [38-42]. We did
not find any differences in non-medical consumption
expenditure between angina-affected households and
controls in Bangladesh, India and Sri Lanka. In Nepal,
on the other hand, there was a statistically significant
difference but in this case, non-medical consumption
expenditure was higher among angina-affected households.
It is difficult to interpret these findings since some authors
suggest that food consumption will be higher in house-
holds with sick individuals owing to the need for special
diets [43,44]. In the WHS data we used, one further source
of confounding is the explicit exclusion of transportation
expenses for accessing health services from reported OOP
expenses in the WHS questionnaire. If, as we expect, trans-
portation expenses for healthcare ended up in non-medical
expenditures that could be another reason for higher-
reported non-medical expenses among angina-affected
households in Nepal. However, WHS data are insufficiently
detailed to permit a fuller assessment of these hypotheses.
Our study has obvious limitations. Our analysis was
based on self-reported household expenditure data which
is subject to measurement error [45,46]. Respondents are
tend to provide socially acceptable answers when they are
asked frequencies or amounts, they may rely on best esti-
mates rather than recalling and counting [47]. The results
of a test-retest study of the WHS specifically found that
respondents in this survey tended to under-report total
household expenditure, and over-report OOP health ex-
penditure [21].
Our treatment variables were self-reported symptom-
based angina and self-reported diagnosed angina, which
are likely to be functions of levels of health awareness
and health seeking behaviour. This might lead to mul-
tiple biases in our results. For example, some unreported
angina cases end up in control households. If so, our es-
timates of economic burden would provide a lower
bound of the economic implications of angina for house-
holds in South Asia. On the other hand, awareness and
diagnosis might be associated with more severe cases of
CVD or greater propensity for health services use. We
tried to control for this possibility by taking account of
comorbidities for which information was available in the
WHS data, but only limited information on such comor-
bidities were available. In this case, our analysis could be
overestimating the economic burden of the average an-
gina case in South Asia. More generally, unobservable
factors that lead might to exclusion of a pool of house-
holds at risk for angina from matched controls could
bias our estimated economic burden of angina upwardsif the excluded households are also at risk for acquiring
other serious illnesses and increased health spending.
Conclusions
Ours is the first paper to explore the economic burden
of angina on households in South Asia. We found that the
burden of OOP spending could be significant on house-
holds that have a member with angina, and that this burden
arises primarily due to outpatient care, including spending
on medicines. Our analysis also suggests that angina may
increase the risk of not working due to illness, although this
effect appears to be small, with the exception of Sri Lanka.
However, we did not find any adverse effects on non-
medical consumption expenditure. Households where a
respondent reported angina also tended to report more
reliance on borrowing or sale of assets to finance OOP
spending relative to controls. These findings underline the
need for policymakers to consider measures to protect
households against not just the hospital expenses associated
with NCDs, but also in outpatient care settings, where con-
ditions such as angina are more likely to be managed.
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